e-learning
resources
Vienna 2003
Sunday 28.09.2003
Clinical aspects of community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The assessment of prognostic rules in patients with community-acquired pneumonia (CAP)
L. V. Koukol, S. A. Pupyshev, A. V. Pupyshev, B. I. Gelzer, V. A. Kudryavceva (Vladivostok, Russia)
Source:
Annual Congress 2003 - Clinical aspects of community-acquired pneumonia
Session:
Clinical aspects of community-acquired pneumonia
Session type:
Thematic Poster Session
Number:
973
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. V. Koukol, S. A. Pupyshev, A. V. Pupyshev, B. I. Gelzer, V. A. Kudryavceva (Vladivostok, Russia). The assessment of prognostic rules in patients with community-acquired pneumonia (CAP). Eur Respir J 2003; 22: Suppl. 45, 973
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Prognostic factors of mortality in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003
Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010
Diagnostic and prognostic utility of procalcitonin (PCT) measurements in patients with hospitalized community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Are there radiographic differences between patients with community-acquired (CAP) and healthcare-associated pneumonias (HCAP)?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 41s
Year: 2007
Value of routine microbial investigation in low-risk patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 420s
Year: 2002
Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 992-993
Year: 2011
Another view on the prediction of outcomes in patients with community-acquired pneumonia
Source: Eur Respir J 2011; 38: 991-992
Year: 2011
Applicability of Fine criteria in patients hospitalized for community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 67s
Year: 2005
Decision making tool in the management of patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2004; 24: Suppl. 48, 538s
Year: 2004
Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011
Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009
Community-acquired pneumonia in COPD patients: GOLD staging is a strong predicting factor of outcome of pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
Source: Eur Respir J 2016; 48: 797-807
Year: 2016
Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007
Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006
Validation of a predictive rule for the management of community-acquired pneumonia
Source: Eur Respir J 2006; 27: 151-157
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept